Overall, ROCK1’s role in insulin signaling is complex, and the opposing effects of adipocyte-specific ROCK1 inhibition in healthy vs. pathological models, indicates an importance of basal ROCK1 activity to glucose homeostasis but also implicates its overactivity in metabolic disease pathologies. Here, ROCK1 is linked to metabolic disease.